These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
175 related articles for article (PubMed ID: 958211)
1. Binding interactions of lysergic acid diethylamide and related agents with dopamine receptors in the brain. Burt DR; Creese I; Snyder SH Mol Pharmacol; 1976 Jul; 12(4):631-8. PubMed ID: 958211 [No Abstract] [Full Text] [Related]
2. The dopamine receptor: differential binding of d-LSD and related agents to agonist and antagonist states. Creese I; Burt DR; Synder SH Life Sci; 1975 Dec; 17(11):1715-9. PubMed ID: 1207384 [No Abstract] [Full Text] [Related]
3. Displacement of specific serotonin and lysergic acid diethylamide binding by Ergalgin, a new antiserotonin drug. Oelszner W Acta Biol Med Ger; 1980; 39(8-9):897-901. PubMed ID: 7282219 [TBL] [Abstract][Full Text] [Related]
4. Proceedings: Action of LSD on supersensitive mesolimbic dopamine receptors. Kelly PH Br J Pharmacol; 1975 Oct; 55(2):291P. PubMed ID: 1201419 [No Abstract] [Full Text] [Related]
6. Bromocriptine, dihydroergotoxine, methysergide, d-LSD, CF25--397, and 29--712: effects on the metabolism of the biogenic amines in the brain of the rat. Bürki HR; Asper H; Ruch W; Züger PE Psychopharmacology (Berl); 1978 May; 57(3):227-37. PubMed ID: 97702 [No Abstract] [Full Text] [Related]
7. Dual actions of lysergic acid diethylamide tartrate (LSD), 2-bromo-D-lysergic acid diethylamide bitartrate (BOL) and methysergide on dorsal root potentials evoked by stimulation of raphe nuclei. Larson AA; Chinn C; Proudfit HK; Anderson EG J Pharmacol Exp Ther; 1981 Apr; 217(1):99-104. PubMed ID: 6110778 [TBL] [Abstract][Full Text] [Related]
8. Brain receptors for dopamine and neuroleptics. Seeman P; Titeler M; Tedesco J; Weinreich P; Sinclair D Adv Biochem Psychopharmacol; 1978; 19():167-76. PubMed ID: 29446 [No Abstract] [Full Text] [Related]
9. Action of dopamine receptor agonists in forebrain and hypothalamus: rotational behavior, ovulation, and dopamine turnover. Fuxe K; Agnati LF; Corrodi H; Everitt BJ; Hökfelt T; Löfström A; Ungerstedt U Adv Neurol; 1975; 9():223-42. PubMed ID: 1146654 [TBL] [Abstract][Full Text] [Related]
10. Inhibition of neurotransmitter receptor binding by ergot derivatives. Hruska RE; Silbergeld EK J Neurosci Res; 1981; 6(1):1-11. PubMed ID: 6111611 [TBL] [Abstract][Full Text] [Related]
11. On the antagonism of ergot alkaloids and dopamine by phenothiazines. Stone TW Experientia; 1974 Jul; 30(7):827-9. PubMed ID: 4847689 [No Abstract] [Full Text] [Related]
12. Methods for assessing the interaction of agents with 5-hydroxytryptamine neurons and receptors in the brain. Jalfre M; Ruch-Monachon MA; Haefely W Adv Biochem Psychopharmacol; 1974; 10():121-34. PubMed ID: 4276951 [No Abstract] [Full Text] [Related]